Table III.
Management of NSTEMI patients (after propensity score matching)
Parameter | Women | Men | ||||
---|---|---|---|---|---|---|
2005–2007 | 2012–2014 | P-value | 2005–2007 | 2012–2014 | P-value | |
17346 (100%) | 17346 (100%) | 26059 (100%) | 26059 (100%) | |||
Treatment strategy: | ||||||
Hospitalisation on cardiology depart. | 12000 (69.2) | 15420 (88.9) | < 0.001 | 19222 (73.8) | 23982 (92.0) | < 0.001 |
Conservative treatment | 11787 (68.0) | 2255 (13.0) | < 0.001 | 15032 (57.7) | 2315 (8.9) | < 0.001 |
Coronary angiography | 5542 (32.0) | 15090 (87.0) | < 0.001 | 10998 (42.3) | 23744 (91.1) | < 0.001 |
Percutaneous coronary intervention | 3838 (22.1) | 10021 (57.8) | < 0.001 | 8015 (30.8) | 16861 (64.7) | < 0.001 |
Second PCI (non-IRA) during indx hosp. | 612 (3.6) | 2268 (13.1) | < 0.001 | 1149 (4.4) | 2849 (10.9) | < 0.001 |
PCI with stent implantation | 3357 (87.5) | 9083 (90.5) | < 0.001 | 7719 (88.9) | 15434 (91.3) | < 0.001 |
PCI with BMS implantation | 3192 (83.2) | 4115 (41.0) | < 0.001 | 6808 (85.0) | 6618 (39.1) | < 0.001 |
PCI with DES implantation | 165 (4.3) | 4968 (49.5) | < 0.001 | 311 (3.9) | 8816 (52.2) | < 0.001 |
Intra aortic ballon pump | 52 (0.3) | 88 (0.5) | 0.023 | 105 (0.4) | 143 (0.5) | 0.016 |
Medical treatment during hospitalisation: | ||||||
Acetlosalycic acid | 15974 (92.1) | 14271 (82.3) | < 0.001 | 24244 (93.0) | 21671 (83.2) | < 0.001 |
P2Y12B inhibitor | 9041 (52.1) | 16096 (92.8) | < 0.001 | 15581 (59.8) | 24281 (93.2) | < 0.001 |
Clopidogrel | 7019 (40.5) | 16040 (92.5) | < 0.001 | 12625 (48.4) | 24243 (93.0) | < 0.001 |
GPIIb/IIIa inhibitor | 371 (2.1) | 1318 (7.6) | < 0.001 | 880 (3.4) | 2619 (10.1) | < 0.001 |
Heparin | 12949 (74.7) | 8919 (51.5) | < 0.001 | 18988 (72.9) | 13152 (50.5) | < 0.001 |
Beta-adrenolytic | 13705 (79.0) | 11607 (66.9) | < 0.001 | 20499 (78.7) | 17790 (68.3) | < 0.001 |
Calcium channel blocker | 1664 (9.8) | 2228 (12.8) | < 0.001 | 2032 (7.8) | 2878 (11.0) | < 0.001 |
Statin | 13633 (78.6) | 12311 (71.0) | < 0.001 | 21050 (80.8) | 19224 (73.8) | < 0.001 |
ACEI/ARB | 13616 (78.8) | 10529 (60.7) | < 0.001 | 20166 (77.4) | 16286 (62.6) | < 0.001 |
Nitrate | 9366 (54.0) | 2496 (14.4) | < 0.001 | 13015 (49.9) | 3448 (13.2) | < 0.001 |
Diuretics | 6903 (39.8) | 5100 (29.4) | < 0.001 | 8082 (31.0) | 6326 (24.3) | < 0.001 |
ACEI/ARB – angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, BMS – bare metal stent, DES – drug eluting stent, IRA – infarct-related artery.